Endocare, a medical device company focused on the development of minimally invasive
technologies for tissue and tumor ablation along with vacuum technologies for
erectile dysfunction, reported that it has completed a private placement of
5,635,378 newly issued shares of its common stock raising approximately $15.6
million in gross proceeds.
LifeSciencesWorld (http://www.lifesciencesworld.com/news/news-5164.htm)